Senior insider sale
Chief Financial Officer at AMBRX BIOPHARMA, INC. — senior position signals high conviction
$125.5K
12.78K shares
What this filing means
NELSON SONJA plans to sell 12.78K shares of AMBRX BIOPHARMA, INC. valued at approximately $125.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/27/2023ACC: 0001970051-23-000018
Officer· Chief Financial Officer
Since Oct 2023
12.78K
Shares to sell
$125.5K
Approx. market value
12.78K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RESTRICTED STOCK UNIT COMMON STOCK
COMPENSATORY PAYMENT
10/27/2023
12.78KTotal acquired12.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/27/2023 | RESTRICTED STOCK UNIT COMMON STOCK COMPENSATORY PAYMENT | 12.78K | — |
| Total | 12.78K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
12.78K
Market value
$125.5K
10/27/2023
Total
Units
12.78K
Value
$125.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/27/2023 | 12.78K | $125.5K | NASDAQ | Planned |
| Total | 12.78K | $125.5K | ||